Health Effects of Non-Clinical Psychedelic Use
This summer, I will be continuing my research in conjunction with UC Berkeley, UCSF, and the Global Initiative for Psychedelic Science Economics (GIPSE) to determine the health outcomes that result from psychedelic usage. This project aims to investigate the biomedical and behavioral effects of using MDMA, 2C-B, 2C-I, Ibogaine, Ketamine, and Salvinorin in a non-clinical setting. Through this work, I hope to determine the chronic health impacts of “non-classical,” highly-stigmatized psychedelics and make knowledge around the materials more accessible and transparent. I am fascinated by this subject and am looking forward to spending this summer conducting literature reviews and data extraction on past research.
Message To SponsorI have had a close family member undergo a psychedelic treatment for substance abuse. I want to express my upmost gratitude to URAP and its donors for allowing me the privilege to research a subject close to me. Thank you for this opportunity.
Major: Public Health & Political Economy
Mentor: Stefano Bertozzi and Elliot Marseille/ Public Health
Sponsor: Cheunkarndee Fund